Triphosphopyridine nucleotide sodium salt hydrate structure
|
Common Name | Triphosphopyridine nucleotide sodium salt hydrate | ||
|---|---|---|---|---|
| CAS Number | 698999-85-8 | Molecular Weight | 765.38700 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C21H27N7NaO17P3 | Melting Point | 175-178ºC (dec.)(lit.) | |
| MSDS | USA | Flash Point | N/A | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of Triphosphopyridine nucleotide sodium salt hydrateNADP sodium hydrate, a β-Nicotinamide adenine dinucleotide phosphate sodium salt, is a redox cofactor. NADP sodium hydrate is a key cofactor for electron transfer in the metabolism, being alternately oxidized (NADP+) and reduced (NADPH)[1][2]. |
| Name | sodium,[[5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-oxidophosphoryl] [5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate |
|---|---|
| Synonym | More Synonyms |
| Description | NADP sodium hydrate, a β-Nicotinamide adenine dinucleotide phosphate sodium salt, is a redox cofactor. NADP sodium hydrate is a key cofactor for electron transfer in the metabolism, being alternately oxidized (NADP+) and reduced (NADPH)[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Melting Point | 175-178ºC (dec.)(lit.) |
|---|---|
| Molecular Formula | C21H27N7NaO17P3 |
| Molecular Weight | 765.38700 |
| Exact Mass | 765.05700 |
| PSA | 400.87000 |
| InChIKey | CYQLUFJYVTUUFN-WUEGHLCSSA-M |
| SMILES | NC(=O)c1ccc[n+](C2OC(COP(=O)([O-])OP(=O)([O-])OCC3OC(n4cnc5c(N)ncnc54)C(OP(=O)(O)O)C3O)C(O)C2O)c1.O.[Na+] |
| Storage condition | -20°C |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H319 |
| Precautionary Statements | P280-P305 + P351 + P338-P337 + P313 |
| Hazard Codes | Xn |
| RIDADR | NONH for all modes of transport |
|
Modulation of cytochrome P450 2A5 activity by lipopolysaccharide: low-dose effects and non-monotonic dose-response relationship.
PLoS ONE 10(1) , e0117842, (2015) Mouse cytochrome P450 (CYP) 2A5 is induced by inflammatory conditions and infectious diseases that down-regulate the expression and activity of most other CYP isoforms. Enhanced oxidative stress and n... |
|
|
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets.
Nat. Rev. Drug Discov. 10 , 453-471, (2011) NADPH oxidases are a family of enzymes that generate reactive oxygen species (ROS). The NOX1 (NADPH oxidase 1) and NOX2 oxidases are the major sources of ROS in the artery wall in conditions such as h... |
|
|
The role of free radical generation in increasing cerebrovascular permeability.
Free Radic. Biol. Med. 51 , 967-977, (2011) The brain endothelium constitutes a barrier to the passive movement of substances from the blood into the cerebral microenvironment, and disruption of this barrier after a stroke or trauma has potenti... |
| |A-Nicotinamide adenine dinucleotide phosphate sodium salt hydrate |
| Triphosphopyridine nucleotide sodium salt hydrate |